The 'shock and kill' therapeutic strategy for treating HIV could potentially cause harmful neuroinflammation, a new study reveals.
Researchers report a new 'hangover drug' can decrease blood alcohol levels by 45% in just four hours. Mice given the drug woke from their alcohol induce sleep faster and with less hangover symptoms than those who did not receive the medication.
Researchers report our gender can determine longevity and response to treatment for glioblastoma brain cancer. The study reports male survival is determined by genes that control cell division, where as female survival is often determine by genes that regulate the ability of cancer cells to migrate to different brain areas.
Sestrin, a naturally occurring compound, mimics many of the effects of exercise in mouse and fly models. The findings could help with the development of medications to help combat muscle wasting associated with aging and neurodegenerative diseases.
Researchers report the chronic use of drugs to treat heartburn and GERDS can increase the risk of cardiovascular disease, vascular dementia and renal failure.
A new study reports paracetamol (acetaminophen) could damage the development of male behaviors in offspring if taken while a female is pregnant.
Researchers report the commonly used pain medication, acetaminophen, is associated with an increased risk of behavioral problems in offspring when taken during pregnancy.
Researchers have discovered an elevated rate of language delay in 30 month old girls born to mothers who took the pain killer acetaminophen during pregnancy. The delay, however, was not witnessed in boys.
A new study reveals ADHD increases the risk of sexually transmitted infections in adolescents threefold compared to the general population. However, the use of ADHD medications reduces the risk of STIs in males by up to 41%.
UCSF researchers reveal a common over the counter antihistamine appears to accelerate neural signaling and restore nervous system functioning for some multiple sclerosis patients.
Researchers have identified a possible new drug target that could help to restore memory loss and improve longevity in Alzheimer's disease.
Researchers report a drug developed to target amyloid plaques in those with Alzheimer's does not significantly slow cognitive decline.